Five Prime Therapeutics, Inc.

FMR LLC

Report date

12/31/2020

Quarter

2020 Q4

Filed

2/8/2021

Shares

864,288

Value ($000)

14,701

Weight

0.0%

2019 Q4 - 2020 Q4 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q4	2/8/2021	14,701	0.0%	864,288	12/31/2020
2020 Q3	11/13/2020	2	0.0%	400	9/30/2020
2020 Q1	5/14/2020	3	0.0%	1,250	3/31/2020
2019 Q4	2/7/2020	2	0.0%	500	12/31/2019